MENU
SGMO
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Sangamo Therapeutics (SGMO) Ownership - Who owns Sangamo Therapeutics?

Sangamo Therapeutics Inc is a genomic medicine company committed to translating ground-breaking science into medicines that transform the lives of patients and families afflicted with serious neurological diseases... Show more

Industry: #Biotechnology

Profile

Industry
Biotechnology
Address
501 Canal Boulevard
Phone
+1 510 970-6000
Employees
142
Web
https://www.sangamo.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
50.13M
P/E Ratio
N/A
Total Cash
29.62M
Projected Growth
N/A
Total Debt
25.42M
Revenue
32.88M
Risk (Beta)
2.31
Dividend Yield
N/A
Total Cash/Share
0.07
Total Debt/Equity
N/A
Revenue/Share
0.14 USD as % of share price
View a ticker or compare two or three
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

a developer of transcription factors in the regulation of genes

Industry Biotechnology

Profile
Details
Industry
Biotechnology
Address
501 Canal Boulevard
Phone
+1 510 970-6000
Employees
142
Web
https://www.sangamo.com